Alamar Biosciences, Inc., a trailblazer in precision proteomics, announced today the successful raising of $10 million in funding to expand its groundbreaking technologies and enhance its product offerings. With a mission to revolutionize protein analysis, Alamar leverages its proprietary NULISAâ„¢ Chemistry and the advanced ARGOâ„¢ System to provide automated, high throughput solutions that deliver ultra-high sensitivity analyses across various multiplex levels. The recent funding will primarily support the development and commercialization of its NULISAseq Inflammation Panel, which features over 200 critical markers associated with immune and inflammatory diseases. This cutting-edge panel enables rapid, reliable readouts using both qPCR and NGS technologies, ensuring that researchers and clinicians have access to vital data to inform their work. The efficiencies offered by the ARGOâ„¢ System allow for less than 30 minutes of hands-on time from sample to data, significantly improving laboratory workflow and precision. With this latest round of funding, Alamar Biosciences aims to accelerate the deployment of its innovative solutions, driving advancements in disease research and diagnostics. By enhancing sensitivity and dynamic range while reducing background signals compared to traditional methods, Alamar is poised to make a substantial impact in the realm of proteomics, ultimately helping to advance healthcare outcomes. This is an exciting time for both the company and its stakeholders, as they collectively embark on a journey to unlock new insights into protein functions and interactions that could lead to groundbreaking therapies and interventions.
Alamar Biosciences Announces $10M Funding Boost to Revolutionize Precision Proteomics
Recently funded · $10.0MBiotechnology
Get the full Alamar Biosciences, Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
